FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience. [electronic resource]
Producer: 20170529Description: 649-54 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers, Tumor -- analysis
- CA-19-9 Antigen -- analysis
- Camptothecin -- administration & dosage
- Carcinoma, Pancreatic Ductal -- drug therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Drug Substitution
- Female
- Fluorouracil -- administration & dosage
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Irinotecan
- Kaplan-Meier Estimate
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Ontario
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Quality of Life
- Sepsis -- etiology
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.